Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q3

2796.TEDINET S100T8YK
Period2023-06-01 → 2024-02-29
Filed2024-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥40.7bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥52.0bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥38.7bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income¥863m2023-06-01 → 2024-02-29Cons.Operating income
Operating income¥896m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income¥799m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.4bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥890m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥761m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥722m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥177m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥333m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥208m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥187m2023-06-01 → 2024-02-29Cons.Profit loss
Net income¥218m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥26.4bnat 2024-02-29Cons.Assets
Total assets¥23.4bnat 2023-05-31Cons.Assets
Total assets¥22.9bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥18.5bnat 2024-02-29Cons.Liabilities
Total liabilities¥16.4bnat 2023-05-31Cons.Liabilities
Net assets / equity¥8.0bnat 2024-02-29Cons.Net assets
Net assets / equity¥7.0bnat 2023-05-31Cons.Net assets
Net assets / equity¥6.8bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥5.2bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥4.7bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥17.222023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.422023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.452022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.242022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.452022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.482023-06-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.892022-06-01 → 2023-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥16.892022-06-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio29.0%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio28.5%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-06-01 → 2024-02-29¥593m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-06-01 → 2024-02-29¥593m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-06-01 → 2024-02-29¥5m
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2024-02-29−¥250m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2023-06-01 → 2024-02-29¥6.2bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2023-06-01 → 2024-02-29¥6.2bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2023-06-01 → 2024-02-29−¥45m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2023-06-01 → 2024-02-29¥456m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2023-06-01 → 2024-02-29¥456m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2023-06-01 → 2024-02-29¥33m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2023-06-01 → 2024-02-29¥33.1bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2023-06-01 → 2024-02-29¥33.1bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2023-06-01 → 2024-02-29¥1.0bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2023-06-01 → 2024-02-29¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2023-06-01 → 2024-02-29¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2023-06-01 → 2024-02-29¥83m
—segment totalrevenue2023-06-01 → 2024-02-29¥40.1bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥40.1bn
—segment totalsegment profit2023-06-01 → 2024-02-29¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥40.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥40.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥37m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥226m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2023-02-28−¥170m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2023-02-28¥56m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.1bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥70m
—segment totalrevenue2022-06-01 → 2023-02-28¥38.2bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥38.2bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 396
ItemContextValueUnit
Deferred assetsCurrentQuarterInstant－JPY
AssetsPrior1YearInstant23421000000JPY
AssetsCurrentQuarterInstant26425000000JPY
Accounts payable tradePrior1YearInstant4252000000JPY
Accounts payable tradeCurrentQuarterInstant4917000000JPY
Current portion of bondsPrior1YearInstant1482000000JPY
Current portion of bondsCurrentQuarterInstant－JPY
Current portion of long term loans payablePrior1YearInstant2008000000JPY
Current portion of long term loans payableCurrentQuarterInstant2263000000JPY
Income taxes payablePrior1YearInstant333000000JPY
Income taxes payableCurrentQuarterInstant231000000JPY
Provision for bonusesPrior1YearInstant45000000JPY
Provision for bonusesCurrentQuarterInstant279000000JPY
Provision for loss on store closingPrior1YearInstant21000000JPY
Provision for loss on store closingCurrentQuarterInstant42000000JPY
Other clPrior1YearInstant1691000000JPY
Other clCurrentQuarterInstant990000000JPY
Current liabilitiesPrior1YearInstant9835000000JPY
Current liabilitiesCurrentQuarterInstant8724000000JPY
Long term loans payablePrior1YearInstant5216000000JPY
Long term loans payableCurrentQuarterInstant8300000000JPY
Net defined benefit liabilityPrior1YearInstant791000000JPY
Net defined benefit liabilityCurrentQuarterInstant898000000JPY
Asset retirement obligations nclPrior1YearInstant111000000JPY
Asset retirement obligations nclCurrentQuarterInstant120000000JPY
Other nclPrior1YearInstant478000000JPY
Other nclCurrentQuarterInstant426000000JPY
Noncurrent liabilitiesPrior1YearInstant6598000000JPY
Noncurrent liabilitiesCurrentQuarterInstant9746000000JPY
LiabilitiesPrior1YearInstant16433000000JPY
LiabilitiesCurrentQuarterInstant18470000000JPY
Capital stockPrior1YearInstant1298000000JPY
Capital stockCurrentQuarterInstant1961000000JPY
Capital surplusPrior1YearInstant1553000000JPY
Capital surplusCurrentQuarterInstant2177000000JPY
Retained earningsPrior1YearInstant4014000000JPY
Retained earningsCurrentQuarterInstant4059000000JPY
Treasury stockPrior1YearInstant-210000000JPY
Treasury stockCurrentQuarterInstant-550000000JPY
Shareholders equityPrior1YearInstant6655000000JPY
Shareholders equityCurrentQuarterInstant7647000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-0JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant－JPY
Remeasurements of defined benefit plansPrior1YearInstant18000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant17000000JPY
Valuation and translation adjustmentsPrior1YearInstant17000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant17000000JPY
Subscription rights to sharesPrior1YearInstant208000000JPY
Subscription rights to sharesCurrentQuarterInstant208000000JPY
Non controlling interestsPrior1YearInstant105000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass